Dennis Douroumis

Hot-Melt Extrusion

Pharmaceutical Applications

• Gebundenes Buch

Produktbeschreibung

Hot-melt extrusion (HME) - melting a substance and forcing itthrough an orifice under controlled conditions to form a newmaterial - is an emerging processing technology in thepharmaceutical industry for the preparation of various dosage formsand drug delivery systems, for example granules and sustainedrelease tablets.
Hot-Melt Extrusion: Pharmaceutical Applications coversthe main instrumentation, operation principles and theoreticalbackground of HME. It then focuses on HME drug delivery systems,dosage forms and clinical studies (including pharmacokinetics andbioavailability) of HME products. Finally, the book includes somerecent and novel HME applications, scale -up considerations andregulatory issues. Topics covered include:
principles and die design of single screw extrusion
twin screw extrusion techniques and practices in the laboratoryand on production scale
HME developments for the pharmaceutical industry
solubility parameters for prediction of drug/polymermiscibility in HME formulations
the influence of plasticizers in HME
applications of polymethacrylate polymers in HME
HME of ethylcellulose, hypromellose, and polyethyleneoxide
bioadhesion properties of polymeric films produced by HME
taste masking using HME
clinical studies, bioavailability and pharmacokinetics of HMEproducts
injection moulding and HME processing for pharmaceuticalmaterials
laminar dispersive & distributive mixing with dissolutionand applications to HME
technological considerations related to scale-up of HMEprocesses
devices and implant systems by HME
an FDA perspective on HME product and processunderstanding
improved process understanding and control of an HME processwith near-infrared spectroscopy
Hot-Melt Extrusion: Pharmaceutical Applications is anessential multidisciplinary guide to the emerging pharmaceuticaluses of this processing technology for researchers in academia andindustry working in drug formulation and delivery, pharmaceuticalengineering and processing, and polymers and materials science.
This is the first book from our brand new series Advancesin Pharmaceutical Technology. Findout more about the series here.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Advances in Pharmaceutical Technology
• Verlag: Wiley & Sons
• 1. Auflage
• Seitenzahl: 384
• Erscheinungstermin: 25. Juni 2012
• Englisch
• Abmessung: 250mm x 175mm x 26mm
• Gewicht: 869g
• ISBN-13: 9780470711187
• ISBN-10: 0470711183
• Artikelnr.: 35046516

Autorenporträt

Dennis Douroumis University of Greenwich, UK

Inhaltsangabe

List of Contributors xv
Preface xvii
1. Single-screw Extrusion: Principles 1
Keith Luker
1.1 Introduction 1
1.2 Ideal Compounding 2
1.3 Basics of the Single-screw Extruder 3
1.3.1 Screw Feed Section 5
1.3.2 Screw Compressor Section 9
1.3.3 Screw Metering Section 11
1.3.4 Mixers 11
1.3.5 Limitations of Conventional Single-screw Mixers 13
1.4 SSE Elongational Mixers 13
1.5 Summary 20
References 21
2. Twin-screw Extruders for Pharmaceutical Hot-melt Extrusion: Technology,
Techniques and Practices 23
Dirk Leister, Tom Geilen and Thobias Geissler
2.1 Introduction 23
2.2 Extruder Types and Working Principle 24
2.3 Individual Parts of a TSE 25
2.3.1 Drive Unit 25
2.3.2 Screws 25
2.3.3 Screw Elements 27
2.3.4 Distributive Flow Elements 28
2.3.5 Discharge Feed Screw 28
2.3.6 Barrel 29
2.4 Downstreaming 30
2.5 Individual Processing Sections of the TSE 31
2.5.1 Feeding Section 32
2.5.2 Conveying/Melting Section 32
2.5.3 Mixing Section 33
2.5.4 Venting Section 33
2.5.5 Extrusion Section 33
2.6 Feeding of Solids 34
2.7 TSE Operating Parameters 34
2.7.1 Filling Level 36
2.7.2 Screw Speed 36
2.7.3 Feed Rate 37
2.7.4 Residence Time Distribution 37
2.7.5 Effect of Screw Speed and Feed Rate on Melt Temperature 39
2.8 Setting up an HME Process using QbD Principles 40
2.8.1 Understanding Knowledge Space 40
2.8.2 Defining Design Space 40
2.8.3 Determining Control Space 41
2.9 Summary 42
References 42
3. Hot-melt Extrusion Developments in the Pharmaceutical Industry 43
Ana Almeida, Bart Claeys, Jean Paul Remon and Chris Vervaet
3.1 Introduction 43
3.2 Advantages of HME as Drug Delivery Technology 44
3.3 Formulations used for HME Applications 45
3.3.1 Active Pharmaceutical Ingredient 46
3.3.2 Solid Dispersions 48
3.3.3 Bioavailability Improvement 49
3.3.4 Controlled Delivery Systems 51
3.3.5 Plasticizers 53
3.4 Characterization of Extrudates 55
3.4.1 Thermal Analysis 55
3.4.2 Atomic Force Microscopy 56
3.4.3 Residence Time 57
3.4.4 Spectroscopic Techniques 57
3.4.5 X-ray Diffraction (XRD) 58
3.4.6 Microscopy 58
3.4.7 Drug Release 58
3.5 Hot-melt Extruded Dosage Forms 58
3.5.1 Oral Drug Delivery 59
3.5.2 Films 61
3.5.3 Vaginal Rings and Implants 61
3.6 A View to the Future 63
References 64
4. Solubility Parameters for Prediction of Drug/Polymer Miscibility in
Hot-melt Extruded Formulations 71
Andreas Gryczke
4.1 Introduction 71
4.2 Solid Dispersions 72
4.3 Basic Assumptions for the Drug-polymer Miscibility Prediction 77
4.4 Solubility and the Flory-Huggins Theory 78
4.5 Miscibility Estimation of Drug and Monomers 83
4.6 Summary 89
References 90
5. The Influence of Plasticizers in Hot-melt Extrusion 93
Geert Verreck
5.1 Introduction 93
5.2 Traditional Plasticizers 94
5.3 Non-traditional Plasticizers 95
5.4 Specialty Plasticizers 104
5.5 Conclusions 107
References 108
6. Applications of Poly(meth)acrylate Polymers in Melt Extrusion 113
Kathrin Nollenberger and Jessica Albers
6.1 Introduction 113
6.2 Polymer Characteristics 116
6.2.1 Chemical Structure and Molecular Weight 116
6.2.2 Glass Transition Temperature 119
6.2.3 Plasticizers 120
6.2.4 Thermostability 121
6.2.5 Viscosity 122
6.2.6 Specific Heat Capacity 124
6.2.7 Hygroscopicity 126
6.3 Melt Extrusion of Poly(methacrylates) to Design Pharmaceutical Oral
Dosage Forms 128
6.4 Solubility Enhancement 128
6.5 Bioavailability Enhancement of BCS Class IV Drugs 132
6.5.1 Controlled Release 135
6.5.2 Time-controlled-release Dosage Forms 136
6.5.3 pH-dependent Release 138
6.5.4 Taste Masking 139
6.6 Summary 140
References 140
7. Hot-melt Extrusion of Ethylcellulose, Hypromellose and Polyethylene
Oxide 145
Mark Hall and Michael Read
7.1 Introduction 145
7.2 Background 146
7.3 Thermal Properties 147
7.4 Processing Aids/Additives 147
7.5 Unconventional Processing Aids: Drugs, Blends 149
7.6 Case Studies 151
7.6.1 Ethylcellulose 151
7.6.2 Combinations of Excipients 151
7.6.3 Solubilization 155
7.6.4 Film 159
7.6.5 Unique Dosage Forms 163
7.6.6 Abuse Resistance 163
7.6.7 Controlled Release 164
7.6.8 Solubility Parameters 166
7.7 Milling of EC, HPMC and PEO Extrudate 168
References 170
8. Bioadhesion Properties of Polymeric Films Produced by Hot-melt Extrusion
177
Joshua Boateng and Dennis Douroumis
8.1 Introduction 177
8.2 Anatomy of the Oral Cavity and Modes of Drug Transport 180
8.2.1 Structure 180
8.2.2 Modes of Drug Transport and Kinetics 180
8.2.3 Factors Affecting Drug Absorption 181
8.3 Mucoadhesive Mechanisms 182
8.4 Factors Affecting Mucoadhesion in the Oral Cavity 183
8.5 Determination of Mucoadhesion and Mechanical Properties of Films 183
8.6 Bioadhesive Films Prepared by HME 184
8.7 Summary 194
References 194
9. Taste Masking Using Hot-melt Extrusion 201
Dennis Douroumis, Marion Bonnefille and Attila Aranyos
9.1 The Need and Challenges for Masking Bitter APIs 201
9.2 Organization of the Taste System 203
9.2.1 Taste Perception in Humans and Organization of Peripheral System 203
9.2.2 Transduction of Taste Signals 205
9.3 Taste Sensing Systems (Electronic Tongues) for Pharmaceutical Dosage
Forms 206
9.3.1 Alpha MOS Electronic Tongue: Instrumentation and Operational
Principles 206
9.3.2 Taste Analysis 208
9.3.3 Taste Masking Efficiency Testing 209
9.3.4 Advantages of E-tongue Taste Analysis 211
9.4 Hot-melt Extrusion: An Effective Means of Taste Masking 212
9.4.1 Taste Masking via Polymer Extrusion 212
9.4.2 Taste Masking via Solid Lipid Extrusion 216
9.5 Summary 219
References 219
10. Clinical and Preclinical Studies, Bioavailability and Pharmacokinetics
of Hot-melt Extruded Products 223
Sandra Guns and Guy Van den Mooter
10.1 Introduction to Oral Absorption 223
10.2 In Vivo Evaluation of Hot-melt Extruded Solid Dispersions 225
10.2.1 Oral Immediate Release 225
10.2.2 Oral Controlled Release 232
10.2.3 Implants 233
10.3 Conclusion 234
References 234
11. Injection Molding and Hot-melt Extrusion Processing for Pharmaceutical
Materials 239
Pernille Høyrup Hemmingsen and Martin Rex Olsen
11.1 Introduction 239
11.2 Hot-melt Extrusion in Brief 240
11.3 Injection Molding 241
11.4 Critical Parameters 242
11.4.1 Melt Temperature 242
11.4.2 Barrel Temperature 243
11.4.3 Cooling Temperature 243
11.4.4 Holding Pressure 243
11.4.5 Holding Time 243
11.4.6 Back Pressure 244
11.4.7 Injection Speed 244
11.4.8 Cooling Time/Cycle Time 244
11.5 Example: Comparison of Extruded and Injection-molded Material 245
11.6 Development of Products for Injection Molding 246
11.6.1 Excipients 246
11.6.2 Stability 248
11.6.3 Process Development 248
11.7 Properties of Injection-molded Materials 251
11.7.1 Egalet® Technology 251
11.7.2 Controlling Physical State by Means of Hot-melt Extrusion and
Injection Molding 253
11.7.3 Anti-tamper Properties of Injection-molded Tablets 254
11.8 Concluding Remarks 257
References 257
12. Laminar Dispersive and Distributive Mixing with Dissolution and
Applications to Hot-melt Extrusion 261
Costas G. Gogos, Huiju Liu and Peng Wang
12.1 Introduction 261
12.2 Elementary Steps in HME 263
12.2.1 Particulate Solids Handling (PSH) 263
12.2.2 Melting 263
12.2.3 Devolatilization 264
12.2.4 Pumping and Pressurization 265
12.3 Dispersive and Distributive Mixing 265
12.4 HME Processes: Cases I and II 265
12.4.1 Case I 266
12.4.2 Case II 268
12.5 Dissolution of Drug Particulates in Polymeric Melt 270
12.5.1 Process Variables 270
12.5.2 Equipment Variables 273
12.5.3 Material Variables 275
12.6 Case Study: Acetaminophen and Poly(ethylene oxide) 278
12.7 Determination of Solubility of APAP in PEO 280
References 282
13. Technological Considerations Related to Scale-up of Hot-melt Extrusion
Processes 285
Adam Dreiblatt
13.1 Introduction 285
13.2 Scale-up Terminology 287
13.2.1 Scale-up: Batch Size 287
13.2.2 Scale-up: Feed Rate 288
13.2.3 Scale-up: Extruder Diameter 290
13.3 Volumetric Scale-up 290
13.3.1 Volumetric Scale-up: Length/Diameter (L/D) 292
13.3.2 Volumetric Scale-up: Diameter Ratio 292
13.3.3 Volumetric Scale-up: Screw Design 294
13.4 Power Scale-up 296
13.5 Heat Transfer Scale-up 298
13.6 Die Scale-up 299
13.7 Conclusion 299
References 300
14. Devices and Implant Systems by Hot-melt Extrusion 301
Andrew Loxley
14.1 Introduction 301
14.2 HME in Device Development 302
14.3 Hot-melt Extruder Types 303
14.4 Comparison of HME Devices and Oral Dosage Forms 305
14.5 HME Processes for Device Fabrication 306
14.5.1 Issues with HME in preparing Drug-eluting Devices 308
14.6 Devices and Implants 310
14.6.1 Anatomical Device Locations 310
14.6.2 Simple Devices 310
14.6.3 Non-medicated Prolonged Tissue Contact Devices 312
14.6.4 Medicated (Drug-eluting) Prolonged Tissue Contact Devices 313
14.7 Release Kinetics 318
14.7.1 Mechanisms of API Release 318
14.7.2 Example In Vitro Drug Elution Profiles 319
14.8 Conclusions 321
References 321
15. Hot-melt Extrusion: An FDA Perspective on Product and Process
Understanding 323
Abhay Gupta and Mansoor A. Khan
15.1 Introduction 323
15.2 Quality by Design 325
15.3 Utilizing QbD for HME Process Understanding 328
References 331
16. Improved Process Understanding and Control of a Hot-melt Extrusion
Process with Near-Infrared Spectroscopy 333
Chris Heil and Jeffrey Hirsch
16.1 Vibrational Spectroscopy Introduction 333
16.2 Near-infrared Method Development 339
16.3 Near-infrared Probes and Fiber Optics 344
16.4 NIR for Monitoring the Start-up of a HME Process 347
16.5 NIR for Improved Process Understanding and Control 350
References 353
Index 355